; and (ii) susceptibility to specific microorganisms and treatment need for multi-drug resistant pathogens; (B) perform other activities, as determined necessary by the Secretary, to support the designation of priority antimicrobial products under subsection (k) and the review and disposition of applications for priority antimicrobial products under subsection (a); and (C) develop recommendations to the Secretary and the Congress regarding other incentives needed to ensure a robust and renewable pipeline of antimicrobial drugs, with priority given to antimicrobial drugs that are first in class, possess a novel mechanism of action, or treat a vulnerable population such as children. (4) Finalization and updating of list of critical need antimicrobials priorities Upon receipt from the Committee of the initial proposed list of critical need antimicrobial priorities or proposed updates to such list, the Secretary shall— (A) provide a period of public notice and comment on the proposal, including by publishing the proposed list on the Internet; (B) hold public meetings to elicit input from stakeholders on the proposal